SGRY Share Price Performance
US$15.84
-7.17 (-31.16%)
34.0% undervalued intrinsic discount
US$24.00
Fair Value
Price US$15.84
AnalystLowTarget US$24.00
AnalystHighTarget US$36.00
AnalystConsensusTarget US$27.91
Fair ValueUS$24.00
Share Pricen/a
Surgery Partners, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
SGRY Community Narratives
AN
Fair Value US$24 34.0% undervalued intrinsic discount
Leverage And CMS Shifts Will Curb Earnings Yet Spark Recovery
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$36 56.0% undervalued intrinsic discount
Aging Population And Minimally Invasive Advances Will Fuel Outpatient Demand
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$27.91 43.2% undervalued intrinsic discount
Outpatient Shifts And CMS Changes Will Expand Surgical Potential
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Outpatient Shifts And CMS Changes Will Expand Surgical Potential
Key Takeaways Strategic investments in advanced procedures, facility enhancements, and physician recruitment enable above-market growth and position the company to benefit from industry migration trends. Regulatory tailwinds and disciplined M&A execution are expanding the addressable market, supporting ongoing margin expansion and stronger long-term earnings potential.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
US$27.91
43.2% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
7.02% p.a.
Profit Margin
3.12%
Future PE
36.52x
Share price in 2028
US$35.37
Aging Population And Minimally Invasive Advances Will Fuel Outpatient Demand
Key Takeaways Accelerated migration of higher-acuity procedures and advanced operational efficiencies could substantially elevate long-term revenue growth and profitability beyond current expectations. Strategic investments in automation, portfolio optimization, and high-quality physician recruitment are poised to create lasting competitive advantages and superior net margin expansion.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$36
56.0% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
10.95% p.a.
Profit Margin
5.32%
Future PE
24.94x
Share price in 2028
US$45.08
Leverage And CMS Shifts Will Curb Earnings Yet Spark Recovery
Key Takeaways Delayed facility openings, slower acquisition benefits, and reimbursement pressures threaten revenue growth and margin improvement despite investments in robotics and higher acuity care. High leverage and competition from larger operators constrain free cash flow and may hinder future growth, even as outpatient surgery demand rises.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$24
34.0% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
8.85% p.a.
Profit Margin
0.58%
Future PE
161x
Share price in 2028
US$29.93
Recently Updated Narratives
AN
Outpatient Shifts And CMS Changes Will Expand Surgical Potential
Fair Value: US$27.91 43.2% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Leverage And CMS Shifts Will Curb Earnings Yet Spark Recovery
Fair Value: US$24 34.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Aging Population And Minimally Invasive Advances Will Fuel Outpatient Demand
Fair Value: US$36 56.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Surgery Partners, Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -1.33
- 23.92%
- -5.21%
- 75.1%
About SGRY
- Founded
- 2004
- Employees
- 15000
- CEO
- WebsiteView website
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; and ancillary services, such as multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
